{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T13:09:15Z","timestamp":1694610555936},"reference-count":23,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.vaccine.2015.07.020","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:33:15Z","timestamp":1437611595000},"page":"4548-4553","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes"],"prefix":"10.1016","volume":"33","author":[{"given":"Ophelie","family":"Godon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexei","family":"Evlachev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryline","family":"Bourgine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Meritet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perrine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Inchauspe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Louise","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.07.020_bib0120","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0125","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0130","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(99)70289-1","article-title":"Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T-cells associated with the control of infection","volume":"117","author":"Maini","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0135","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","article-title":"Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection","volume":"61","author":"Bertoletti","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0140","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2009.12.017","article-title":"The molecular basis of the failed immune response in chronic HBV: therapeutic implications","volume":"52","author":"Maini","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0145","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jhep.2010.12.031","article-title":"Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges","volume":"54","author":"Michel","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1872-034X.2009.00601.x","article-title":"Geographical and genetic diversity of the human hepatitis B virus","volume":"40","author":"Kurbanov","year":"2010","journal-title":"Hepatol Res"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0155","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0160","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2014.03.089","article-title":"Comparative analysis of immunization schedules using a novel adenovirus-based immunotherapeutic targeting hepatitis B in naive and tolerant mouse models","volume":"32","author":"Boukhebza","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0165","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.174.6.1565","article-title":"Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen","volume":"174","author":"Penna","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0170","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/hep.21594","article-title":"Impact of hepatitis B virus basic core promoter mutations on T-cell response to an immunodominant HBx-derived epitope","volume":"45","author":"Malmassari","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0175","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2893.2012.01611.x","article-title":"T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines\/chemokines in chronic hepatitis B patients, ANRS study: HB EP 02 HBSP-FIBRO","volume":"19","author":"Bayard","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0180","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1099\/0022-1317-83-6-1267","article-title":"Genetic variability in hepatitis B viruses","volume":"83","author":"Kidd-Ljunggren","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0185","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1128\/JVI.02619-06","article-title":"Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients","volume":"81","author":"Mancini-Bourgine","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0190","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.4049\/jimmunol.175.9.5675","article-title":"Durable human memory T-cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria","volume":"175","author":"Keating","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0195","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1016\/j.vaccine.2005.08.013","article-title":"Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers","volume":"24","author":"Mancini-Bourgine","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0200","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T-cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy","volume":"78","author":"Webster","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0205","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20011723","article-title":"Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection","volume":"195","author":"Reignat","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0210","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3851\/IMP1982","article-title":"HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B","volume":"16","author":"Kim","year":"2011","journal-title":"Antiviral Ther"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0215","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/hep.510250438","article-title":"Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T-cells in acute self-limited hepatitis B","volume":"25","author":"Penna","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0220","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.4049\/jimmunol.176.7.4003","article-title":"Distinct, cross-reactive epitope specificities of CD8 T-cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypes","volume":"176","author":"Riedl","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0225","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1128\/JVI.01124-08","article-title":"Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire","volume":"82","author":"Tan","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.07.020_bib0230","article-title":"TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T-cells and exerts an antiviral effect in HBV-persistent mice","author":"Martin","year":"2014","journal-title":"Gut"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15009548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T18:56:12Z","timestamp":1537469772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15009548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":23,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0264410X15009548"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}